September 2022 - 9th Edition



Note from a Stroke Warrior and our
Board President, Keith Taylor!!

It is an exciting time for Stroke Awareness Oregon. 

The continued growth and accomplishments that we have seen this year have been extraordinary.

We continue to deepen and strengthen the relationships with partners that help us bring forth new ideas and commitments. The work that is being done not only supports those that need it, but also helps to educate our community about the risks of stroke.

Our Board is made up of very strong and active leaders in our community. Our Board of Directors, along with the team (Executive Director, Chief Development Officer and Executive Assistant) continue to come up with positive, new ideas to bring more solutions to Central Oregon.

As we continue this great work, we are excited for the changes and growth in the stroke community, along with the progress we make for others.

We are committed to the on-going efforts in order to make a difference in our community.  




Welcome to Stroke Awareness Oregon's Walk-n-Wheel-athon!
Saturday, October 22nd, 2022 – 1:00 – 4:00 PST

Trinity Lutheran School
2550 NE Butler Market Rd. Bend, OR 97701

1:00 [Registration] ~ 1:30 [Walk Begins] ~ 3:00 [Winning Teams and Prizes!]

Let's save lives together!

This is Stroke Awareness Oregon’s first Walk-n-Wheel-athon fundraiser!! and we’re more excited than ever! We’re opening this event up to families, businesses, and of course stroke survivors! Whether you’re in a wheelchair, running in top of the line shoes, or taking a casual walk – All endeavors are going to help our organization bring awareness to stroke and provide financial support to our educational impact in the Central Oregon Community!




Jim - Coach at Osteostrong

OsteoStrong & Stroke Rehabilitation

Osteoporosis is a known consequence of Stroke, associated with an increased incidence of fractures, mainly of the hip, leading to further disability. The pattern of bone loss seen in stroke patients is different from that usually encountered with postmenopausal osteoporosis, since it is limited to the paretic side and more evident in the upper extremities. Degree of paresis, gait disability and duration of immobilization are several factors that appear to have an influence on bone mass in stroke patients.
We at the Osteostrong Wellness Center in Bend offer a unique concept designed to deliver the most profound results in skeletal strength conditioning.

By engaging in our system clients can experience
rapid results and increases in their physical strength, energy, agility and balance, reduction or complete elimination of joint and back pain and we see clients reversing their osteoporosis. The unique simplicity and efficiency of the Osteostrong system makes it very easy for our stroke patients to use.
We would love to see you and share the Osteostrong experience. Just give us a call and mention you heard about us through the Stroke Awareness Oregon (SAO) and your first visit with us is free.

OsteoStrong Bend


We got our Berry Check!!! 
The Rotary Club of Redmond was kind enough to donate their annual berry sales to SAO! With this gesture, we were able to raise thousands of dollars to help impact the stroke community. Thank you from the bottom of our hearts to this wonderful organization, this donation will be directly targeted towards our initiative of providing educational outreach throughout the Central Oregon Community to aid in preventing strokes!

Happiness in Giving 


Join our Sustaining Membership - Help Make a Difference!


Try your skills on Brain Game!!!!

Masterpieces Game!

Image Quiz!







On-Going Support Groups 
All are Welcome!  


Join a Support Group via Zoom 

All Access Code: 267 166 8755

2nd & 4th Tuesday @ 3pm Support Group

2nd Monday @ 1pm Caregivers

3rd Monday @ 6pm Young (er)

Featuring Stoke Survivors, Dr's & Therapists from around the Nation.

Group Coordinator Keith Taylor

Click the image below to watch our most recent support group!


Your Pet's Health - YES Pets Can Experience a Stroke. 


Quote of the Day!


Health Central



Cardiomyopathy is Scary. But Today, the Heart Disease is Less Deadly.

Modern medical treatments are allowing more patients to enjoy longer and better lives with the ailment Pennsylvania Lt. Gov. John Fetterman (D) in 2018. He suffered a stroke in May during his campaign for the U.S. Senate. Fetterman's campaign said he is being treated for cardiomyopathy. (Michael S. Williamson/The Washington Post)

Heart disease remains America’s leading killer. But medical innovations have made cardiomyopathy, a.k.a. the scary-sounding condition “heart failure,” less of a threat.

Cardiomyopathy affects millions of Americans and is the leading cause of hospital admissions for those over 65 in the United States. When Pennsylvania Lt. Gov. John Fetterman (D) suffered a stroke during his campaign for the U.S. Senate in May, his campaign revealed that he had been diagnosed with cardiomyopathy.

Cardiomyopathy results from a weakening of the heart muscle that causes the heart to beat less vigorously. As the heart loses strength, it often enlarges to compensate for its lack of squeeze. Clinicians frequently classify the contractions by “ejection fraction” — the percentage of blood the heart is able to squeeze forward. An increasing number of Americans also have heart failure with a normal ejection fraction.

I thought I knew a lot about how to prevent heart disease. I was surprised by what I didn’t know.

Fetterman, 52, is a case study of what can happen if appropriate treatment is not provided or followed. He was diagnosed with “atrial fibrillation, an irregular heart rhythm, along with a decreased heart pump” in 2017 — not an uncommon initial presentation of cardiomyopathy — and given a treatment plan that included lifestyle changes, such as restricting salt intake, losing weight and exercising, and medications that studies show can make a big difference.

But Fetterman failed to follow his doctor’s treatment plan — not even going back to the cardiologist for regular consultations. After his stroke, doctors revealed his cardiomyopathy diagnosis and implanted a defibrillator to prevent a lethal heart rhythm.

As Fetterman put it after his stroke: “Like so many others, and so many men, in particular, I avoided going to the doctor, even though I knew I didn’t feel well. As a result, I almost died.”

I am a heart failure specialist. Patients like Fetterman are why the conversation between doctor and patient after a cardiomyopathy diagnosis is critical. My goal is both to explain the condition and establish a trusting relationship that will result in the patient embracing appropriate follow-up. This can mean walking a fine line between conveying the seriousness of the diagnosis to a patient and avoiding a sense of doom, which many people will feel when told they have heart failure.

Loneliness can increase risk of heart disease by 27 percent for older women

Although I make sure my patients understand they have a serious, life-threatening condition, I add that, these days, many people with cardiomyopathy live long, fulfilling lives.

Studies suggest people are living longer in part because of a plethora of new innovations. The most notable are new medications called SGLT2 inhibitors. Initially developed to treat Type 2 diabetes, they also were found to prolong and improve the lives of patients with heart failure; they also have minimal side effects and can be used for heart failure patients with both reduced or normal ejection fraction.

Unfortunately, because these drugs are new — the first SGLT2 inhibitor was approved by the Food and Drug Administration in 2020 to treat heart failure — many patients likely to benefit from them are not on them, in some cases because many physicians, including cardiologists, have yet to update their practice but also because of high co-pays and administrative burdens placed on clinicians by insurance companies.

Many people get their initial cardiomyopathy diagnosis after they’ve had difficulty breathing or experienced swelling in their extremities because of excess fluid in the body. Once diagnosed, though, many patients enter a stable phase — but staying in that stable phase requires work. Lifestyle changes, such as losing weight, restricting salt intake and exercising, are key for living a long and healthy life with cardiomyopathy, as is taking medications regularly as prescribed by a physician.

The evidence suggests that taking four core categories of medications can add between three and eight years of life, in addition to the years added by lifestyle changes. These drug categories include: beta blockers (drugs that end in “-olol,” like metoprolol), ACE inhibitors (these end in “-pril,” like lisinopril) or ARBs (that end in “-artan,” like losartan) or the brand drug Entresto, MRAs such as spironolactone and, lastly, the SGLT2 inhibitors (that end in “-flozin,” such as empagliflozin and dapagliflozin). Clinicians should explain both the many benefits and the few risks of the drugs while imparting a sense of agency and ownership to patients.

“You are the quarterback, and we are your offensive line protecting you from being hit,” I often tell people.

Sometimes, even the best efforts don’t work — or work for only so long — and patients enter a more advanced stage of heart failure characterized by recurrent admissions to the hospital, an inability to tolerate medications due to low blood pressure and in some cases a progressive failure of organs such as the kidneys and lungs. Patients experience progressive difficulty in breathing, initially only when they are exercising and eventually even at rest.

Sleep joins the list of eight key factors for heart health

When this happens, doctors may recommend surgical treatments, such as a heart transplant or implantation of mechanical pumps that are sutured into the patient’s heart to help pump blood throughout the body. Survival after heart transplantation is on average 13 years, with many patients living beyond two decades. The mechanical pumps, called left ventricular assist devices or LVADs, have also come a long way and can add years more of life.

Both heart transplant and LVADs carry significant risks: rejection of the donor heart, infections and cancers can affect heart transplant recipients; and bleeding, infections and strokes affect LVAD recipients. Because the risks often exceed the benefits, many patients are not good candidates for these therapies. At that stage, patients may turn to palliative care that focuses on maximizing quality of life and comfort-focused care rather than just length of life, although patients with heart failure may benefit from palliative care at any stage of their illness.

Because cardiomyopathy remains a challenging and burdensome disease, we need to maximize all efforts to prevent heart failure in the first place. For most people, this means controlling blood pressure and diabetes, losing weight and preventing other forms of heart disease, including abnormal heart rhythms and heart attacks, that can lead to heart failure.

Yet treatments for cardiomyopathy have transformed it from a death sentence to a condition that many people can live with better and longer than ever before. Given advancements in science and medicine, there’s hope it will become an even less frightening diagnosis in the future. For that to happen, it is critical for patients to get the right care at the right time.

Haider J. Warraich is a cardiologist at Brigham and Women’s Hospital, VA Boston Healthcare System and Harvard Medical School. He is the author of “State of the Heart: Exploring the History, Science and Future of Cardiac Disease and the just-published book “The Song of Our Scars: The Untold Story of Pain.”





9/21 10am to Noon Madres Senior Health Fair

9/22 9am to 5pm 16th Annual Stroke Conference Riverhouse Convention Center

9/24 9am to 5pm Bend Health Fair Riverhouse Convention Center




Many years ago this tree fell over. 

It did not give up! Although fallen it still had the will to Thrive!

Having trouble viewing this email? View it in your web browser

Unsubscribe or Manage Your Preferences